Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge

NCT02422121 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: RNS60
DRUG: Placebo

Sponsor

Revalesio Corporation